scispace - formally typeset
A

Arthur M. Feldman

Researcher at Thomas Jefferson University

Publications -  296
Citations -  41891

Arthur M. Feldman is an academic researcher from Thomas Jefferson University. The author has contributed to research in topics: Heart failure & Tumor necrosis factor alpha. The author has an hindex of 79, co-authored 289 publications receiving 40355 citations. Previous affiliations of Arthur M. Feldman include Johns Hopkins University School of Medicine & Valley Hospital.

Papers
More filters
Journal ArticleDOI

The role of tumor necrosis factor alpha in the pathophysiology of congestive heart failure.

TL;DR: Recent studies in both animal models and clinical investigations suggest that anti-TNF-α therapies may limit the pathophysiologic consequences of congestive heart failure.
Journal ArticleDOI

The Multifunctional Protein BAG3: A Novel Therapeutic Target in Cardiovascular Disease.

TL;DR: The B-cell lymphoma 2–associated anthanogene (BAG3) protein is expressed most prominently in the heart, the skeletal muscle, and in many forms of cancer, where it serves as a co-chaperone with heat shock proteins in facilitating autophagy.
Journal ArticleDOI

The balance between pro-apoptotic and anti-apoptotic pathways in the failing myocardium.

TL;DR: It is important to note that the adrenergic, reactive oxygen species, and proinflammatory cytokine signaling pathways are not the only pro-apoptotic pathways active in the myocardium, nor are IL-6-related cytokine, calcineurin, and IGF-1/P13K/Akt signaling pathways the only anti-apopotic pathwaysActive in theMyocardium.